Press Releases

Roger Morgan Joins Clinipace as Executive Vice President, Global Medical Affairs

Clinipace Worldwide, a global digital contract research organization (dCRO), announced today the addition of Dr. Roger Morgan, MD, FACS, as Executive Vice President, Global Medical Affairs. Dr. Morgan has extensive experience in global medical affairs with both pharmaceutical companies and CROs. While trained as a surgeon/critical care intensivist, he spent much of his industry career focused on cardiovascular research.

more

Karyopharm Therapeutics Inc. Enters into Preferred Provider Agreement with Clinipace Worldwide

Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today that Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, has entered into a preferred provider agreement with Clinipace to manage several clinical programs, including oncology, wound healing, and other diseases.

more

Nexstim Selects Clinipace Worldwide to Manage Clinical Trial

Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today that Nexstim, a leader in navigated stimulation of the brain, has selected the company to manage the US-based clinical trial for its Navigated Brain Therapy (NBT) System.

more

Clinipace Worldwide Expands into Asia with Acquisition of Choice Pharma

Clinipace Worldwide, a global digital contract research organization (dCRO), announced today the closing of its merger with Choice Pharma, a Pan-Asian contract research organization. Bringing these organizations together strengthens Clinipace Worldwide’s operational and therapeutic expertise in Asia, a region in high demand by Clinipace’s clients.

more

Phosphate Therapeutics Selects Clinipace Worldwide to Manage its Phase 2 Renal Study

Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today that Phosphate Therapeutics, co-owned and resourced by Shield Therapeutics (Shield), an independent specialty pharmaceutical company, has selected the company to manage its first pivotal trial in its late stage Nephrology program expected to commence in 2014.

more

Clinipace Worldwide Has Banner Year in 2013

Clinipace Worldwide announced today the company has closed its strongest year to date, with a record number of new clinical development projects and regulatory and strategic development engagements; driving 114% growth in bookings compared to the previous year.

more

Clinipace Worldwide Honored as a 2013 Inc. Hire Power Award Winner

Clinipace Worldwide, a global digital clinical research organization (dCRO), has announced the company has been named to Inc. Magazine’s 2nd annual Hire Power Awards. This list recognizes private, U.S.-based businesses that have generated the most jobs over the past eighteen months.

more

Mark Ubert Joins Clinipace Worldwide as Chief Financial Officer

Clinipace Worldwide, a global digital contract research organization (dCRO), today announced the addition of Mark Ubert as Chief Financial Officer.  He brings more than 25 years of experience in various finance and accounting leadership roles, including more than 15 years in CFO-level positions in the life sciences and healthcare industries. 

more
Clinipace Worldwide
© 2013 CLINIPACE. All Rights Reserved. Website Privacy Statement | US-EU Safe Harbor | eLinks